The HCPWP, established in 2013, has enabled the Agency to build upon its existing interactions with healthcare professionals. It provides recommendations to the EMA and its human scientific committees on all matters of interest in relation to medicines.
The following documents provide information on the HCPWP's responsibilities and composition:
Meetings
For information on upcoming and past meetings of the PCWP, including meeting materials, see:
Composition
The HCPWP consists of:
- a core group of representatives from the eligible healthcare professionals' organisations;
- representatives from EMA's scientific committees;
- observers from:
- the EMA Management Board;
- the European Commission.
- the Patients' and Consumers' Working Party;
- the Coordination Group for Mutual Recognition and Decentralised Procedures - Human.
The members' declarations of interests are available in the European experts list.
Co-chairs
Affiliation | Co-chairs |
---|---|
EMA | Juan Garcia Burgos |
European Society for Medical Oncology (ESMO) | Rosa Giuliani |
Organisation representative members
Members representing EMA scientific committees
EMA Scientific Committee | Representative(s) |
---|---|
Committee for Advanced Therapies | Alessandro Aiuti Federica Chiara |
Committee for Medicinal Products for Human Use | Fàtima Ventura |
Committee for Orphan Medicinal Products | Elisabeth Johanne Rook |
Committee for Herbal Medicinal Products | Olga Maria Palomino An Le |
Paediatric Committee | Johannes Taminiau Eleni Katsomiti |
Pharmacovigilance Risk Assessment Committee | Roberto Frontini |
Observers
Affiliation | Representative(s) |
---|---|
EMA Management Board | Denis Lacombe |
Patients' and Consumers' Working Party (alternating) | Angela Bradshaw Kaisa Immonen |
European Commission (DG SANTE) | Rotating membership |
Coordination Group for Mutual Recognition and Decentralised Procedures - Human (CMDh) | Jitka Vokrouhlická Nina Malvik |